Connor, Clark & Lunn Investment Management Ltd. Alkermes Plc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Alkermes Plc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 28,699 shares of ALKS stock, worth $850,925. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,699
Previous 203,441 85.89%
Holding current value
$850,925
Previous $4.9 Million 83.62%
% of portfolio
0.0%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$23.01 - $28.55 $4.02 Million - $4.99 Million
-174,742 Reduced 85.89%
28,699 $803,000
Q2 2024

Aug 09, 2024
BUY
$23.21 - $27.24 $240,548 - $282,315
10,364 Added 5.37%
203,441 $4.9 Million
Q1 2024

May 09, 2024
SELL
$26.4 - $32.56 $4.25 Million - $5.25 Million
-161,133 Reduced 45.49%
193,077 $5.23 Million
Q4 2023

Feb 09, 2024
SELL
$23.37 - $28.68 $5.43 Million - $6.66 Million
-232,382 Reduced 39.62%
354,210 $9.83 Million
Q3 2023

Nov 13, 2023
SELL
$27.17 - $31.97 $1.26 Million - $1.48 Million
-46,337 Reduced 7.32%
586,592 $16.4 Million
Q2 2023

Aug 10, 2023
SELL
$28.34 - $33.63 $166,299 - $197,340
-5,868 Reduced 0.92%
632,929 $19.8 Million
Q1 2023

May 09, 2023
SELL
$25.31 - $29.02 $17,210 - $19,733
-680 Reduced 0.11%
638,797 $18 Million
Q4 2022

Feb 10, 2023
BUY
$21.94 - $26.24 $9.81 Million - $11.7 Million
446,993 Added 232.22%
639,477 $16.7 Million
Q3 2022

Nov 10, 2022
BUY
$22.0 - $31.87 $540,188 - $782,535
24,554 Added 14.62%
192,484 $4.3 Million
Q2 2022

Aug 05, 2022
BUY
$26.4 - $30.54 $4.43 Million - $5.13 Million
167,930 New
167,930 $5 Million
Q4 2021

Feb 10, 2022
SELL
$21.47 - $32.08 $1.43 Million - $2.14 Million
-66,746 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$23.37 - $32.13 $1.56 Million - $2.14 Million
66,746 New
66,746 $2.06 Million
Q1 2021

May 13, 2021
SELL
$18.21 - $23.2 $346,463 - $441,403
-19,026 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$15.39 - $22.1 $292,810 - $420,474
19,026 New
19,026 $380,000
Q2 2020

Aug 13, 2020
SELL
$13.31 - $19.41 $3.54 Million - $5.16 Million
-265,785 Closed
0 $0
Q1 2020

May 13, 2020
SELL
$13.06 - $21.24 $932,888 - $1.52 Million
-71,431 Reduced 21.18%
265,785 $3.83 Million
Q4 2019

Feb 12, 2020
BUY
$17.29 - $21.74 $4.3 Million - $5.4 Million
248,466 Added 279.96%
337,216 $6.88 Million
Q3 2019

Nov 13, 2019
BUY
$19.51 - $24.28 $1.73 Million - $2.15 Million
88,750 New
88,750 $1.73 Million

Others Institutions Holding ALKS

# of Institutions
362
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.87B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email